Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases

被引：0
|
作者：
J A C M Goos
A C Hiemstra
V M H Coupé
B Diosdado
W Kooijman
P M Delis-Van Diemen
C Karga
J A M Beliën
C W Menke-van der Houven van Oordt
A A Geldof
G A Meijer
O S Hoekstra
R J A Fijneman
机构：
[1] VU University Medical Center,Department of Pathology
[2] VU University Medical Center,Department of Radiology & Nuclear Medicine
[3] VU University Medical Center,Department of Epidemiology and Biostatistics
[4] VU University Medical Center,Department of Medical Oncology
来源：
British Journal of Cancer | 2014年 / 111卷
关键词：
colorectal cancer; liver metastasis; prognostic biomarker; EGFR; PTGS2;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：749 / 755
页数：6
相关论文
共 50 条
  • [41] Epidermal growth factor receptor (EGFR) mRNA expression levels are strongly correlated between primary colorectal cancer and corresponding liver metastases
    Kuramochi, H.
    Hayashi, K.
    Uchida, K.
    Yamamoto, M.
    Danenberg, K. D.
    Danenberg, P. V.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [42] VEGFA and SLC2A1 are prognostic biomarkers for patients with resectable colorectal cancer liver metastases
    Goos, Jeroen A. C. M.
    de Cuba, Erienne M. V.
    Coupe, Veerle M. H.
    Diosdado, Begona
    Delis-van Diemen, Pien M.
    Karga, Cemile
    Belien, Jeroen A. M.
    van Oordt, C. Willemien Menke-Van der Houven
    Geldof, Albert A.
    Meijer, Gerrit A.
    Hoekstra, Otto S.
    Fijneman, Remond J. A.
    CANCER RESEARCH, 2015, 75
  • [43] Biomarkers of Resistance to Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer
    Banck, Michaela S.
    Grothey, Axel
    CLINICAL CANCER RESEARCH, 2009, 15 (24) : 7492 - 7501
  • [44] The coexpression and prognostic significance of c-MET, fibroblast growth factor receptor 2, and human epidermal growth factor receptor 2 in resected gastric cancer: a retrospective study
    Jia, Yong-Xu
    Li, Teng-Fei
    Zhang, Dan-Dan
    Fan, Zong-Min
    Fan, Hui-Jie
    Yan, Jie
    Chen, Li-Juan
    Tang, Hong
    Qin, Yan-Ru
    Li, Xing-Ya
    ONCOTARGETS AND THERAPY, 2016, 9 : 5919 - 5929
  • [45] Expression of Human Epidermal Growth Factor Receptor-2 in Resected Rectal Cancer
    Meng, Xiangjiao
    Huang, Zhaoqin
    Di, Jian
    Mu, Dianbin
    Wang, Yawei
    Zhao, Xianguang
    Zhao, Hanxi
    Zhu, Wanqi
    Li, Xiaolin
    Kong, Lingling
    Xing, Ligang
    MEDICINE, 2015, 94 (47) : e2106
  • [46] Genetic variations of tumor necrosis factor-? and prostaglandin-endoperoxide synthase 2 genes among Egyptian patients with type 2 diabetes mellitus and diabetic nephropathy
    Khalifa, Amany Salah
    Elshebiny, Ahmed
    Eed, Emad Mohamed
    Elhelbawy, Mohammed G.
    Rizk, Sara Kamal
    GENE REPORTS, 2022, 29
  • [47] Epidermal growth factor receptor (EGFR) as a predictive and prognostic marker in patients with advanced colorectal cancer (aCRC): The MRC COIN trial experience
    Adams, R. A.
    James, M. D.
    Smith, C. G.
    Wilson, R. H.
    Fisher, D.
    Kenny, S. L.
    Kaplan, R. S.
    Stoerkel, S.
    Maughan, T. S.
    Jasani, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [48] Epidermal growth factor receptor (EGFR) gene promoter methylation and cetuximab treatment in colorectal cancer patients
    Scartozzi, M.
    Bearzi, I.
    Mandolesi, A.
    Giampieri, R.
    Faloppi, L.
    Galizia, E.
    Loupakis, F.
    Zaniboni, A.
    Zorzi, F.
    Biscotti, T.
    Labianca, R.
    Falcone, A.
    Cascinu, S.
    BRITISH JOURNAL OF CANCER, 2011, 104 (11) : 1786 - 1790
  • [49] Epidermal growth factor receptor (EGFR) gene promoter methylation and cetuximab treatment in colorectal cancer patients
    M Scartozzi
    I Bearzi
    A Mandolesi
    R Giampieri
    L Faloppi
    E Galizia
    F Loupakis
    A Zaniboni
    F Zorzi
    T Biscotti
    R Labianca
    A Falcone
    S Cascinu
    British Journal of Cancer, 2011, 104 : 1786 - 1790
  • [50] ASO Author Reflections: Circulating Tumor Cell Count is a Prognostic Factor in Patients with Resected Colorectal Cancer Liver Metastases
    Virginia Arrazubi
    Annals of Surgical Oncology, 2019, 26 : 842 - 842
12345